Ironwood Pharmaceuticals receives 'hold' rating from Jefferies amid insider selling…
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
What happened
Jefferies Financial Group upgraded Ironwood Pharmaceuticals to a “hold” rating in a research report issued on Friday. This rating change occurred alongside disclosures of insider selling filed with the SEC. Ironwood Pharmaceuticals recently reported quarterly earnings that missed consensus estimates for both revenue and EPS.
From themarketsdaily.com
Why it matters
The analyst rating change, combined with the disclosure of insider selling, affects investor sentiment regarding Ironwood Pharmaceuticals. The company’s recent quarterly results showed a negative return on equity of 58.38% and a net margin of 33.36%.
From themarketsdaily.com
Who's involved
- Ironwood PharmaceuticalsBiotechnology company subject to analyst ratings and SEC disclosure requirements
- Jefferies Financial GroupFinancial services company that issued the 'hold' rating upgrade
- SECRegulatory body that received the insider selling disclosures
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Ironwood PharmaceuticalsSpeculative
The company might see changes in stock demand or funding based on the analyst rating and insider selling disclosures.
How it developed
Newest first. Tap a step to see who reported it.Jefferies raised shares of Ironwood Pharmaceuticals.1 source
Analyst upgrade to 'hold' rating for Ironwood Pharmaceuticals; insider selling disclosed via legal filing.1 source
Keep exploring
The entities involved
-
Ironwood Pharmaceuticals
company in Cambridge, United States
Nothing else this week.
-
Jefferies Financial Group
American financial services company
-
SEC
Slovak company
Related events
- Jefferies reaffirmed a 'hold' rating on monday.com Ltd. on October 22, 2026.
- Jefferies Financial Group cut the stock rating for Carlsberg Group to 'hold' on October 13, 2026.
- BHC received a 'hold' rating from Jefferies, while MarketBeat provided consensus data and the board initiated a stock buyback plan.
- Jefferies Financial Group lowered its stock rating for Siemens from buy to hold.
- Analyst rating targets are affecting stock prices, and required reports regarding ownership stakes are being filed with the SEC for Bank of America and KBR, Inc.